ArticleJournal of clinical medicine2026

First-Line Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data from Turkey.

Mustafa Murat Mıdık et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.